S&P 500   2,611.45 (+4.93%)
DOW   22,103.97 (+4.99%)
QQQ   192.39 (+4.92%)
AAPL   253.52 (+5.02%)
FB   160.71 (+4.24%)
MSFT   161.34 (+4.88%)
GOOGL   1,149.47 (+5.19%)
AMZN   1,958.94 (+2.75%)
CGC   13.78 (+4.00%)
NVDA   261.50 (+7.21%)
BABA   194.34 (+3.86%)
MU   44.66 (+8.35%)
GE   7.11 (+5.65%)
TSLA   504.17 (+5.03%)
AMD   45.91 (+7.80%)
ACB   0.80 (-1.23%)
F   4.53 (+6.84%)
NFLX   370.75 (+2.49%)
BAC   20.88 (+4.24%)
GILD   76.62 (-2.03%)
DIS   97.62 (+3.98%)
PRI   86.47 (+7.16%)
S&P 500   2,611.45 (+4.93%)
DOW   22,103.97 (+4.99%)
QQQ   192.39 (+4.92%)
AAPL   253.52 (+5.02%)
FB   160.71 (+4.24%)
MSFT   161.34 (+4.88%)
GOOGL   1,149.47 (+5.19%)
AMZN   1,958.94 (+2.75%)
CGC   13.78 (+4.00%)
NVDA   261.50 (+7.21%)
BABA   194.34 (+3.86%)
MU   44.66 (+8.35%)
GE   7.11 (+5.65%)
TSLA   504.17 (+5.03%)
AMD   45.91 (+7.80%)
ACB   0.80 (-1.23%)
F   4.53 (+6.84%)
NFLX   370.75 (+2.49%)
BAC   20.88 (+4.24%)
GILD   76.62 (-2.03%)
DIS   97.62 (+3.98%)
PRI   86.47 (+7.16%)
S&P 500   2,611.45 (+4.93%)
DOW   22,103.97 (+4.99%)
QQQ   192.39 (+4.92%)
AAPL   253.52 (+5.02%)
FB   160.71 (+4.24%)
MSFT   161.34 (+4.88%)
GOOGL   1,149.47 (+5.19%)
AMZN   1,958.94 (+2.75%)
CGC   13.78 (+4.00%)
NVDA   261.50 (+7.21%)
BABA   194.34 (+3.86%)
MU   44.66 (+8.35%)
GE   7.11 (+5.65%)
TSLA   504.17 (+5.03%)
AMD   45.91 (+7.80%)
ACB   0.80 (-1.23%)
F   4.53 (+6.84%)
NFLX   370.75 (+2.49%)
BAC   20.88 (+4.24%)
GILD   76.62 (-2.03%)
DIS   97.62 (+3.98%)
PRI   86.47 (+7.16%)
S&P 500   2,611.45 (+4.93%)
DOW   22,103.97 (+4.99%)
QQQ   192.39 (+4.92%)
AAPL   253.52 (+5.02%)
FB   160.71 (+4.24%)
MSFT   161.34 (+4.88%)
GOOGL   1,149.47 (+5.19%)
AMZN   1,958.94 (+2.75%)
CGC   13.78 (+4.00%)
NVDA   261.50 (+7.21%)
BABA   194.34 (+3.86%)
MU   44.66 (+8.35%)
GE   7.11 (+5.65%)
TSLA   504.17 (+5.03%)
AMD   45.91 (+7.80%)
ACB   0.80 (-1.23%)
F   4.53 (+6.84%)
NFLX   370.75 (+2.49%)
BAC   20.88 (+4.24%)
GILD   76.62 (-2.03%)
DIS   97.62 (+3.98%)
PRI   86.47 (+7.16%)
Log in

NYSE:PRGOPerrigo Stock Price, Forecast & News

$47.57
+3.21 (+7.24 %)
(As of 04/6/2020 11:50 AM ET)
Add
Compare
Today's Range
$46.32
Now: $47.57
$48.37
50-Day Range
$40.66
MA: $50.85
$60.80
52-Week Range
$40.01
Now: $47.57
$63.86
Volume419,880 shs
Average Volume1.87 million shs
Market Capitalization$6.48 billion
P/E Ratio44.46
Dividend Yield2.03%
Beta1.23
Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments. It offers OTC products in cough, cold, allergy, sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health, diagnostic, lifestyle, personal care and derma-therapeutics, natural health and vitamins, minerals and dietary supplements, feminine hygiene, diabetes care, scar management, and anti-parasite categories under the Good Sense, Sergeant's, Sentry, Zephrex D, PetArmor, and ScarAway brand names. The company also develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectable, hormones, oral solid dosage forms, and oral liquid formulations. In addition, it offers contract manufacturing services. The company offers its products through retail drug, supermarket, and mass merchandise chains; hospitals; pharmacies; wholesalers; drug and grocery stores; and para pharmacies, as well as through a network of pharmacy sales force. It operates in Europe, Australia, Israel, Mexico, the United States, Canada, and China. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Read More
Perrigo logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.5Dividend Strength: 5.0Insider Behavior: 4.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

3.09 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
CUSIP71429010
Phone353-1709-4000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.84 billion
Cash Flow$7.42 per share
Book Value$42.64 per share

Profitability

Net Income$146.10 million

Miscellaneous

Employees11,200
Market Cap$6.48 billion
Next Earnings Date5/13/2020 (Estimated)
OptionableOptionable

Receive PRGO News and Ratings via Email

Sign-up to receive the latest news and ratings for PRGO and its competitors with MarketBeat's FREE daily newsletter.


Perrigo (NYSE:PRGO) Frequently Asked Questions

How has Perrigo's stock been impacted by COVID-19 (Coronavirus)?

Perrigo's stock was trading at $46.04 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, PRGO shares have increased by 3.3% and is now trading at $47.56. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Perrigo?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Perrigo in the last year. There are currently 3 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Perrigo.

When is Perrigo's next earnings date?

Perrigo is scheduled to release its next quarterly earnings announcement on Wednesday, May 13th 2020. View our earnings forecast for Perrigo.

How were Perrigo's earnings last quarter?

Perrigo Company PLC (NYSE:PRGO) posted its quarterly earnings results on Thursday, February, 27th. The company reported $1.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.09 by $0.03. The firm had revenue of $1.32 billion for the quarter, compared to the consensus estimate of $1.31 billion. Perrigo had a return on equity of 9.56% and a net margin of 3.02%. The firm's revenue was up 10.7% on a year-over-year basis. During the same quarter last year, the firm earned $0.97 EPS. View Perrigo's earnings history.

How often does Perrigo pay dividends? What is the dividend yield for Perrigo?

Perrigo declared a quarterly dividend on Tuesday, February 18th. Stockholders of record on Friday, February 28th will be paid a dividend of $0.225 per share on Tuesday, March 17th. This represents a $0.90 dividend on an annualized basis and a dividend yield of 1.89%. The ex-dividend date of this dividend is Thursday, February 27th. This is a positive change from Perrigo's previous quarterly dividend of $0.21. View Perrigo's dividend history.

What guidance has Perrigo issued on next quarter's earnings?

Perrigo issued an update on its FY 2020 Pre-Market earnings guidance on Thursday, February, 27th. The company provided earnings per share guidance of 3.95-4.15 for the period, compared to the Thomson Reuters consensus estimate of $4.37. The company issued revenue guidance of $5.128-5.176 billion, compared to the consensus revenue estimate of $5.02 billion.

What price target have analysts set for PRGO?

8 analysts have issued 12 month price objectives for Perrigo's stock. Their forecasts range from $52.00 to $70.00. On average, they anticipate Perrigo's share price to reach $56.86 in the next twelve months. This suggests a possible upside of 19.5% from the stock's current price. View analysts' price targets for Perrigo.

Has Perrigo been receiving favorable news coverage?

News articles about PRGO stock have been trending very negative on Monday, according to InfoTrie Sentiment. The research firm identifies positive and negative press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Perrigo earned a news sentiment score of -3.3 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news aboutPerrigo.

Are investors shorting Perrigo?

Perrigo saw a increase in short interest during the month of March. As of March 13th, there was short interest totaling 5,269,200 shares, an increase of 11.2% from the February 27th total of 4,740,000 shares. Based on an average daily volume of 1,120,000 shares, the short-interest ratio is presently 4.7 days. Currently, 3.9% of the shares of the stock are short sold. View Perrigo's Current Options Chain.

Who are some of Perrigo's key competitors?

What other stocks do shareholders of Perrigo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Perrigo investors own include Teva Pharmaceutical Industries (TEVA), Gilead Sciences (GILD), Mylan (MYL), Allergan (AGN), Celgene (CELG), Netflix (NFLX), AbbVie (ABBV), Amgen (AMGN), Starbucks (SBUX) and Johnson & Johnson (JNJ).

Who are Perrigo's key executives?

Perrigo's management team includes the following people:
  • Mr. Murray S. Kessler, CEO, Pres & Director (Age 59)
  • Mr. Todd W. Kingma, Exec. VP, Gen. Counsel & Sec. (Age 59)
  • Mr. Jeffrey R. Needham, Exec. VP & Pres of Consumer Healthcare Americas (Age 63)
  • Mr. Svend Andersen, Exec. VP & Pres of Consumer Healthcare International (Age 57)
  • Mr. Ronald L. Winowiecki, Advisory (Age 53)

What is Perrigo's stock symbol?

Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

How do I buy shares of Perrigo?

Shares of PRGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Perrigo's stock price today?

One share of PRGO stock can currently be purchased for approximately $47.56.

How big of a company is Perrigo?

Perrigo has a market capitalization of $6.47 billion and generates $4.84 billion in revenue each year. The company earns $146.10 million in net income (profit) each year or $4.03 on an earnings per share basis. Perrigo employs 11,200 workers across the globe. View additional information about Perrigo.

What is Perrigo's official website?

The official website for Perrigo is http://www.perrigo.com/.

How can I contact Perrigo?

Perrigo's mailing address is THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010. The company can be reached via phone at 353-1709-4000 or via email at [email protected]

This page was last updated on 4/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel